Matthias Möhlig

10.1k total citations · 2 hit papers
111 papers, 7.6k citations indexed

About

Matthias Möhlig is a scholar working on Molecular Biology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Matthias Möhlig has authored 111 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 36 papers in Epidemiology and 33 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Matthias Möhlig's work include Adipokines, Inflammation, and Metabolic Diseases (28 papers), Regulation of Appetite and Obesity (20 papers) and Adipose Tissue and Metabolism (20 papers). Matthias Möhlig is often cited by papers focused on Adipokines, Inflammation, and Metabolic Diseases (28 papers), Regulation of Appetite and Obesity (20 papers) and Adipose Tissue and Metabolism (20 papers). Matthias Möhlig collaborates with scholars based in Germany, United States and United Kingdom. Matthias Möhlig's co-authors include Andreas Pfeiffer, Joachim Spranger, Michael Ristow, Manuela M. Bergmann, Anja Kroke, Heiner Boeing, Martin O. Weickert, Kurt Hoffmann, Heiner Boeing and Christof Schöfl and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Matthias Möhlig

109 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes

2003 1.2k citations Joachim Spranger, Matthias Möhlig et al. profile →
Adiponectin and protection against type 2 diabetes mellitus

2003 911 citations Joachim Spranger, Matthias Möhlig et al. profile →

Peers

Countries citing papers authored by Matthias Möhlig

Since Specialization

Citations

This map shows the geographic impact of Matthias Möhlig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthias Möhlig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthias Möhlig more than expected).

Fields of papers citing papers by Matthias Möhlig

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthias Möhlig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthias Möhlig. The network helps show where Matthias Möhlig may publish in the future.

Co-authorship network of co-authors of Matthias Möhlig

This figure shows the co-authorship network connecting the top 25 collaborators of Matthias Möhlig. A scholar is included among the top collaborators of Matthias Möhlig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthias Möhlig. Matthias Möhlig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rezidivierende Pankreatitiden bei einer 43-jährigen Patientin mit High-Output Stoma 2021 ·Zeitschrift für Gastroenterologie ·(unknown), Matthias Möhlig, Britta Siegmund, Christoph Treese	0
2	Preferential deposition of visceral adipose tissue occurs due to physical inactivity 2014 ·International Journal of Obesity ·Daniel L. Belavý, Matthias Möhlig, Andreas Pfeiffer, Dieter Felsenberg, Gabriele Armbrecht	22
3	Circulating vaspin is unrelated to insulin sensitivity in a cohort of nondiabetic humans 2009 ·European Journal of Endocrinology ·Christian von Loeffelholz, Matthias Möhlig, Ayman M. Arafat, Frank Isken, Joachim Spranger, Knut Mai, Harpal Randeva, Andreas Pfeiffer, Martin O. Weickert	61
4	Metabolic effects of diets differing in glycaemic index depend on age and endogenous glucose-dependent insulinotrophic polypeptide in mice 2009 ·Diabetologia ·Frank Isken, Martin O. Weickert, M. Tschöp, Rubén Nogueiras, Matthias Möhlig, (unknown), Susanne Klaus, Bernard Thorens, Andreas Pfeiffer	30
5	Overexpression of Calcium/Calmodulin-Dependent Protein Kinase II in Insulinoma Cells by use of a Retroviral Vector 2009 ·Experimental and Clinical Endocrinology & Diabetes ·Matthias Möhlig, P. Mayer, Patrick Horn, H. Schatz, Andreas Pfeiffer	0
6	Fatty acids differentially modify the expression of urokinase type plasminogen activator receptor in monocytes 2008 ·Biochemical and Biophysical Research Communications ·Anke Aßmann, Matthias Möhlig, Martin Osterhoff, Andreas Pfeiffer, Joachim Spranger	14
7	Growth Hormone Response during Oral Glucose Tolerance Test: The Impact of Assay Method on the Estimation of Reference Values in Patients with Acromegaly and in Healthy Controls, and the Role of Gender, Age, and Body Mass Index 2008 ·The Journal of Clinical Endocrinology & Metabolism ·Ayman M. Arafat, Matthias Möhlig, Martin O. Weickert, F. H. Perschel, (unknown), Joachim Spranger, Christian J. Strasburger, Christof Schöfl, Andreas Pfeiffer	118
8	Rosiglitazone decreases 11β‐hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue 2007 ·Clinical Endocrinology ·Knut Mai, Janin Andres, Thomas Bobbert, Christiane Maser‐Gluth, Matthias Möhlig, V. Bähr, Andreas Pfeiffer, Joachim Spranger, Sven Diederich	28
9	Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients 2007 ·Kidney International ·Jens Raila, Andrea Henze, Joachim Spranger, Matthias Möhlig, Andreas Pfeiffer, Florian J. Schweigert�	80
10	Cell-type specific regulation of the human 11beta-hydroxysteroid dehydrogenase type 1 promoter 2007 ·Archives of Physiology and Biochemistry ·Janin Andres, Knut Mai, Matthias Möhlig, Martin O. Weickert, Christiane Bumke‐Vogt, Sven Diederich, Andreas Pfeiffer, V. Bähr, Joachim Spranger	3
11	A Thr⁹⁴Ala mutation in human liver fatty acid-binding protein contributes to reduced hepatic glycogenolysis and blunted elevation of plasma glucose levels in lipid-exposed subjects 2007 ·American Journal of Physiology-Endocrinology and Metabolism ·Martin O. Weickert, Christian von Loeffelholz, Michael Roden, Visvanathan Chandramouli, Attila Brehm, P. Nowotny, Martin Osterhoff, Frank Isken, J Spranger, Bernard R. Landau, Andreas Pfeiffer, Matthias Möhlig	39
12	Predictors of abnormal glucose metabolism in women with polycystic ovary syndrome 2006 ·European Journal of Endocrinology ·Matthias Möhlig, Joachim Spranger, Michael Ristow, Andreas Pfeiffer, T. Schill, (unknown), L. Moltz, Georg Brabant, Christof Schöfl	19
13	Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance 2006 ·European Journal of Clinical Nutrition ·Ada L. García, Barbara Otto, S Reich, Martin O. Weickert, Jochen Steiniger, A. Machowetz, Natalia Rudovich, Matthias Möhlig, N. Katz, Maria Speth, F. Meuser, Jürgen Doerfer, (unknown), Andreas Pfeiffer, Corinna Koebnick	144
14	Preliminary Evidence of FABP2 A54T Polymorphism Associated with Reduced Risk of Type 2 Diabetes and Obesity in Women from a German Cohort 2006 ·Hormone and Metabolic Research ·Elizabeth Fisher, Yong Li, Barbara Burwinkel, (unknown), Kurt Hoffmann, Matthias Möhlig, Joachim Spranger, Andreas Pfeiffer, Heiner Boeing, J. Schrezenmeir, Frank Döring	21
15	Arabinoxylan Fibre Consumption Improved Glucose Metabolism, but did not Affect Serum Adipokines in Subjects with Impaired Glucose Tolerance 2006 ·Hormone and Metabolic Research ·Ada L. García, Jochen Steiniger, S Reich, Martin O. Weickert, (unknown), A. Machowetz, Matthias Möhlig, Joachim Spranger, Natalia Rudovich, F. Meuser, Jürgen Doerfer, N. Katz, Maria Speth, H.‐J. Zunft, Andreas Pfeiffer, Corinna Koebnick	55
16	Arabinoxylan-enriched Meal Increases Serum Ghrelin Levels in Healthy Humans 2005 ·Hormone and Metabolic Research ·Matthias Möhlig, Corinna Koebnick, Martin O. Weickert, (unknown), Barbara Otto, Jochen Steiniger, (unknown), F. Meuser, Andreas Pfeiffer, H.‐J. Zunft	50
17	Frataxin deficiency in pancreatic islets causes diabetes due to loss of β cell mass 2003 ·Journal of Clinical Investigation ·Michael Ristow, Hindrik Mulder, (unknown), Tim J. Schulz, (unknown), Anja Krause, Malin Fex, Hélène Puccio, Jörg Müller, Frank Isken, Joachim Spranger, Dirk Müller‐Wieland, Mark A. Magnuson, Matthias Möhlig, Michel Kœnig, Andreas Pfeiffer	107
18	Frataxin deficiency in pancreatic islets causes diabetes due to loss of β cell mass 2003 ·Journal of Clinical Investigation ·Michael Ristow, Hindrik Mulder, (unknown), Tim J. Schulz, (unknown), Anja Krause, Malin Fex, Hélène Puccio, Jörg Müller, Frank Isken, Joachim Spranger, Dirk Müller‐Wieland, Mark A. Magnuson, Matthias Möhlig, Michel Kœnig, Andreas Pfeiffer	7
19	Insulin resistance and impaired insulin secretion due to phosphofructo-1-kinase-deficiency in humans 1999 ·Journal of Molecular Medicine ·Michael Ristow, Matthias Vorgerd, Matthias Möhlig, (unknown), Andreas Pfeiffer	9
20	Circulating Tumor Necrosis Factor α is Elevated in Male but Not in Female Patients With Type II Diabetes Mellitus 1997 ·Hormone and Metabolic Research ·Andreas Pfeiffer, (unknown), Matthias Möhlig, Michael Ristow, H. Rochlitz, (unknown), H. Schatz, E. Schifferdecker	54

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact